Bayer indicates it could pay US$6-US$8 billion but plaintiffs' lawyers want more than US$10 billion to drop the case.
The drug is being recommended for adults and children with difficult to treat forms of cancer that are driven by a rare genetic mutation known as NTRK gene fusion, the European Medicines Agency (EMA) says.
The Boston private equity firm Yellow Wood Partners will pay US$585 million for Bayer's Doctor Scholl's business, which generated US$234 million in revenues last year.
'Instead of investing in sound science, they invested millions in attacking science that threatened their business agenda.'
Bayer said it had suspended cooperation with the external service provider for now.
The French investigation is the latest fallout from Bayer's US$63 billion takeover of Monsanto.
Plaintiffs are becoming bolder after winning the first two trials against Bayer.
More than 55% of shareholders voted that they no longer have confidence in Baumann.
55.5% of shareholders voted against absolving Baumann of responsibility for their actions in the Monsanto takeover last year.
Plaintiffs accused the drugmakers of having failed to warn about the bleeding risks.
Bayer sold off part of its existing seeds and pesticides businesses to rival BASF to get the Monsanto deal past competition authorities.
A court in Lyon ruled that the approval granted by French environment agency ANSES in 2017 for Roundup Pro 360 failed to take into account potential health risks.
Elliott wants the company’s management and board to evaluate breaking Bayer into separate pharmaceutical and agrochemical makers.
Investors have been watching Bayer anxiously as legal risks over the chemical pile up for seeds and pesticides maker Monsanto, which by the end of October faced some 9,300 cases over glyphosate alone.
Bayer, which bought Monsanto this year for US$63 billion, says decades of scientific studies and real-world use have shown glyphosate to be safe for human use.
With thousands of other cancer patients' cases against Monsanto pending in the US, the size of the ruling spooked investors, and shares in Bayer are still down 23.6% since January.
Bayer, which bought Monsanto earlier this year for US$63 billion, faces more than 8,000 similar lawsuits in the United States.
ZURICH: Bayer AG's Monsanto unit has urged a California judge to toss the $289-million verdict a jury awarded to a man who said the...
The group's crop science unit is set to overtake pharmaceuticals as its biggest sales generator, although prescription medicines command a higher profit margin.
Glyphosate remains the world’s most popular and widely used weedkiller - alternatives are nastier chemicals which creates a host of environmental problems.
The trial was an important test of the evidence against Monsanto and will serve as a template for litigating thousands of other claims over the herbicide.
German chemicals and pharmaceuticals giant, Bayer, will withdraw its controversial Essure contraceptive implants from sale in the United States.
Brazil is set to become Bayer's main driver of growth and its second-largest market.
Executives are betting big on projections that around 10 billion people will live on Earth by 2050, meaning more food must grow on the same amount of arable land.
12Page 1 of 2